Rhythm Biosciences Limited (ASX:RHY)

Rhythm Biosciences Revenue

In the fiscal year ending June 30, 2026, Rhythm Biosciences had annual revenue of 1.74M AUD, down -47.67%. Rhythm Biosciences had revenue of 118.58K in the half year ending June 30, 2026, with 126.81% growth.

• Revenue: 1.74M
• Revenue Growth: -47.67%
• P/S Ratio: 16.26
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 28.31M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	1.74M	-1.59M	-47.67%
Jun 30, 2025	3.33M	1.58M	90.90%
Jun 30, 2024	1.74M	-1.35M	-43.72%
Jun 30, 2023	3.10M	668.44K	27.54%
Jun 30, 2022	2.43M	1.32M	118.98%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 15, 2026

Data Sources Report a data error